Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Howard E. Gendelman
Based on 24 articles published since 2010
(Why 24 articles?)
||||
Expertise Level
The expertise of Howard E. Gendelman ranks in the
  • Top 0.53%
  • ... of 88,588 published authors worldwide on Parkinson Disease
  • ... from 2010 through 2020
  • ... based on contributions to 24 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    University of Nebraska System      
2019
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. · Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA. · Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA; Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA. Electronic address: · Pubmed 30421721
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE, United States. · Longevity Biotech, Inc., Philadelphia, PA, United States. · Pubmed 31619964
2018
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE, USA. · Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE, USA. · Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, 985930 Nebraska Medical Center, Omaha, NE 68198-5930, USA. · Pubmed 29783988
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE, 68198, USA. · Department of Medicine, Infectious Diseases Division, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. · Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE, 68198, USA. · Pubmed 29594983
2017
  • Department of Neurological Sciences, University of Nebraska Medical Center (UNMC), Omaha, NE, USA; Center for Magnetoencephalography, UNMC, Omaha, NE, USA. · Department of Neurology, Neurology Consultants of Nebraska, Omaha, NE, USA. · Department of Pharmacology & Experimental Neuroscience, UNMC, Omaha, NE, USA. · Department of Neurological Sciences, University of Nebraska Medical Center (UNMC), Omaha, NE, USA; Center for Magnetoencephalography, UNMC, Omaha, NE, USA; Department of Pharmacology & Experimental Neuroscience, UNMC, Omaha, NE, USA. · Pubmed 28271041
2016
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA. · Department of Public Health Sciences, Environmental Health Laboratory, University of Hawaii at Manoa, Honolulu, HI, 96822, USA. · Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA. · Department of Public Health Sciences, Environmental Health Laboratory, University of Hawaii at Manoa, Honolulu, HI, 96822, USA. · Pubmed 27352074
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. · Department of Radiology, University of Nebraska Medical Center, Omaha, NE, USA. · Longevity Biotech, Philadelphia, PA, USA. · Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. · Pubmed 27329163
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198, USA. Electronic address: · Pubmed 26571205
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska. · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska. · Neurology Consultants of Nebraska, Omaha, Nebraska. · Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska. · Pubmed 27151624
2015
  • Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Department of Pharmacology and Experimental Neuroscience, Omaha, NE, 68198-5880, USA. · Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Department of Pharmacology and Experimental Neuroscience, Omaha, NE, 68198-5880, USA. · Pubmed 26520433
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska 68198 and. · Longevity Biotech, Inc., Philadelphia, Pennsylvania 19104. · Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska 68198 and · Pubmed 26674871
2014
  • Department of Psychology, University of Nebraska, Omaha, Nebraska; Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; Department of Physical Therapy, Munroe-Meyer Institute, University of Nebraska Medical Center, Omaha, Nebraska; · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; · Neurology Consultants of Nebraska, Omaha, Nebraska; · Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska; and. · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska; and Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska · Pubmed 25008416
2013
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Pubmed 24210793
  • Department of Pharmaceutical Sciences, Center for Drug Delivery and Nanomedicine, University of Nebraska Medical Center, Omaha, Nebraska, USA. · Pubmed 23620794
2012
  • Movement Disorders Program, Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska 68198, USA. · Pubmed 22315722
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA. · Pubmed 22166440
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA. · Pubmed 23054369
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Pubmed 22776646
2011
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Pubmed 22091596
  • Center for Drug Delivery & Nanomedicine, University of Nebraska, Omaha, NE, USA. · Pubmed 21449849
2010
  • Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA. · Pubmed 20394532
Possible:    Rush-Presbyterian St. Luke's Medical Center   Contact    
2012
  • Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA. · Pubmed 22723850
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 24 total) written by Howard E. Gendelman about Parkinson Disease:

  • Neurotheranostics as personalized medicines. 2019
  • A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease. 2019
  • Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease. 2018
  • Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice. 2018
  • The cortical signature of symptom laterality in Parkinson's disease. 2017
  • Neuropharmacologic Approaches to Restore the Brain's Microenvironment. 2016
  • Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease. 2016
  • Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease. 2016
  • Quiet connections: Reduced fronto-temporal connectivity in nondemented Parkinson's Disease during working memory encoding. 2016
  • A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders. 2015
Show List of Full Article Records
Google Searches

Learn more about Howard E. Gendelman using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Nebraska System
Rush-Presbyterian St. Luke's Medical Center
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Nebraska System
2019
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. · Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA. · Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA; Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA. Electronic address: · Pubmed 30421721
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE, United States. · Longevity Biotech, Inc., Philadelphia, PA, United States. · Pubmed 31619964
2018
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE, USA. · Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE, USA. · Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, 985930 Nebraska Medical Center, Omaha, NE 68198-5930, USA. · Pubmed 29783988
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE, 68198, USA. · Department of Medicine, Infectious Diseases Division, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. · Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE, 68198, USA. · Pubmed 29594983
2017
  • Department of Neurological Sciences, University of Nebraska Medical Center (UNMC), Omaha, NE, USA; Center for Magnetoencephalography, UNMC, Omaha, NE, USA. · Department of Neurology, Neurology Consultants of Nebraska, Omaha, NE, USA. · Department of Pharmacology & Experimental Neuroscience, UNMC, Omaha, NE, USA. · Department of Neurological Sciences, University of Nebraska Medical Center (UNMC), Omaha, NE, USA; Center for Magnetoencephalography, UNMC, Omaha, NE, USA; Department of Pharmacology & Experimental Neuroscience, UNMC, Omaha, NE, USA. · Pubmed 28271041
2016
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA. · Department of Public Health Sciences, Environmental Health Laboratory, University of Hawaii at Manoa, Honolulu, HI, 96822, USA. · Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA. · Department of Public Health Sciences, Environmental Health Laboratory, University of Hawaii at Manoa, Honolulu, HI, 96822, USA. · Pubmed 27352074
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. · Department of Radiology, University of Nebraska Medical Center, Omaha, NE, USA. · Longevity Biotech, Philadelphia, PA, USA. · Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. · Pubmed 27329163
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198, USA. Electronic address: · Pubmed 26571205
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska. · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska. · Neurology Consultants of Nebraska, Omaha, Nebraska. · Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska. · Pubmed 27151624
2015
  • Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Department of Pharmacology and Experimental Neuroscience, Omaha, NE, 68198-5880, USA. · Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Department of Pharmacology and Experimental Neuroscience, Omaha, NE, 68198-5880, USA. · Pubmed 26520433
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska 68198 and. · Longevity Biotech, Inc., Philadelphia, Pennsylvania 19104. · Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska 68198 and · Pubmed 26674871
2014
  • Department of Psychology, University of Nebraska, Omaha, Nebraska; Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; Department of Physical Therapy, Munroe-Meyer Institute, University of Nebraska Medical Center, Omaha, Nebraska; · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; · Neurology Consultants of Nebraska, Omaha, Nebraska; · Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska; and. · Center for Magnetoencephalography, University of Nebraska Medical Center, Omaha, Nebraska; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska; and Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska · Pubmed 25008416
2013
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Pubmed 24210793
  • Department of Pharmaceutical Sciences, Center for Drug Delivery and Nanomedicine, University of Nebraska Medical Center, Omaha, Nebraska, USA. · Pubmed 23620794
2012
  • Movement Disorders Program, Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska 68198, USA. · Pubmed 22315722
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA. · Pubmed 22166440
  • Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA. · Pubmed 23054369
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Pubmed 22776646
2011
  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Pubmed 22091596
  • Center for Drug Delivery & Nanomedicine, University of Nebraska, Omaha, NE, USA. · Pubmed 21449849
2010
  • Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA. · Pubmed 20394532
Unspecified
2014
  • Department of Psychology, University of Nebraska, Omaha, NE, USA, Center for Magnetoencephalography. · Department of Pharmacology and Experimental Neuroscience, Department of Neurological Sciences, Center for Magnetoencephalography. · Department of Neurology, Neurology Consultants of Nebraska, Omaha, NE, USA. · Department of Neurological Sciences. · Department of Pharmacology and Experimental Neuroscience. · Department of Biostatistics, University of Nebraska Medical Center (UNMC), Omaha, NE, USA and. · Pubmed 23645717
Rush-Presbyterian St. Luke's Medical Center
2012
  • Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA. · Pubmed 22723850
Yearly article counts 02214222531
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.